The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently. 

Speaking on the new role, Sridhar said, “I am honoured to take over the responsibility of leading this prestigious organisation at this important juncture for healthcare in India. I look forward to making a difference to patients, the industry and the country as OPPI works with the government on policies that are pro-patient, encourage innovation and provide for a positive environment for the industry to grow. I thank members of the OPPI Executive Committee for selecting me for this role.”

Welcoming Sridhar as President, Tyagi said, “It is a pleasure to welcome Sridhar as the new President. I am confident that under his stellar leadership, OPPI will charter a new path in the emerging healthcare order of the country where research and innovation are taking deep roots as foundations of the economy.

Sridhar is a Chartered Accountant and has led various finance roles before joining Pfizer Ltd. At Pfizer Ltd, he expanded from his role as Chief Financial Officer to Business Unit head, took over the responsibility as the Managing Director of India Commercial Business, a position he has been holding for the past five years.